TipRanks
Go Ultimate55% OFF

Jason Paul Steik Insider Profile

4 Followers

Jason Paul Steik, Chief Clinical Officer at Pennant Group, holds 15.11K shares in Pennant Group (Ticker: PNTG). Most recently, Jason Paul Steik Sold 1,394 shares of Pennant Group on Aug 10, 2026 for an estimated value of $53.70K.

Jason Paul Steik's Trading History

PNTG
Pennant Group
Aug 10, 2026Chief Clinical OfficerInformative Sell53.70K$629.32K
PNTG
Insider Shares: 15.11K (0.04%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 10, 2026Informative Sell$53.70K1,394$38.52―

You May Also Like

Jason Paul Steik insider profile FAQ

What stocks does Jason Paul Steik hold?
Jason Paul Steik holds: PNTG stocks.
What was Jason Paul Steik’s latest transaction?
Jason Paul Steik’s latest transaction was an Informative Sell of $53.70K.
What is Jason Paul Steik's role in Pennant Group?
Jason Paul Steik's role in Pennant Group is Chief Clinical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.